HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

neuropeptide Y (3-36)

an angiogenic factor from the sympathetic nerves and endothelium

Also Known As:

NPY 3-36

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Neuropeptide Y: 2712
        neuropeptide Y (3-36): 3
- Peptides: 82426
  - Neuropeptides: 6772
    - Neuropeptide Y: 2712
      - neuropeptide Y (3-36): 3
  - Peptide Fragments: 373
    - neuropeptide Y (3-36): 3

Experts

1.	McCloskey, Jaclyn: 1 article (04/2020)
2.	Nahvi, Roxanna J: 1 article (04/2020)
3.	Nwokafor, Chiso: 1 article (04/2020)
4.	Sabban, Esther L: 1 article (04/2020)
5.	Serova, Lidia I: 1 article (04/2020)
6.	Chen, S H: 1 article (01/2003)
7.	Cheung, R T F: 1 article (01/2003)

Related Diseases

1.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/01/2003 - "In this study, we investigated the effects of an i.c.v. injection of a neuropeptide Y-Y2 receptor agonist, neuropeptide Y 3-36, a Y1 receptor agonist, [Leu(31),Pro(34)]-neuropeptide Y, or a Y1 receptor antagonist, BIBP3226, on infarct volume and hemodynamic parameters following middle cerebral artery occlusion. "
2.	Infarction (Infarctions) 01/01/2003 - "When compared with an infarct volume of 17.4+/-4.4% of the ipsilateral hemisphere following injection of neuropeptide Y 3-36, administration of the Y1 receptor analogs significantly modified the infarct volume (ordinary one-way analysis of variance (ANOVA), P<0.0001). " 01/01/2003 - "In this study, we investigated the effects of an i.c.v. injection of a neuropeptide Y-Y2 receptor agonist, neuropeptide Y 3-36, a Y1 receptor agonist, [Leu(31),Pro(34)]-neuropeptide Y, or a Y1 receptor antagonist, BIBP3226, on infarct volume and hemodynamic parameters following middle cerebral artery occlusion. "
3.	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/01/2020 - "To investigate the role of individual NPY receptors in the resilience effects of NPY to traumatic stress, intranasal infusion of either Y1R agonists [D-His26]NPY, [Leu31Pro34]NPY, Y2R agonist NPY (3-36) or NPY were administered to male Sprague-Dawley rats immediately following the last stressor of the single prolonged stress (SPS) protocol, a widely used PTSD animal model. "
4.	Somatostatinoma 06/11/1993 - "A somatostatinoma, resected from the region of the ampulla of Vater, contained 3.8 nmol/g of NPY immunoreactivity and isolation of this immunoreactive peptide followed by structural analyses, indicated a molecular structure consistent with NPY 3-36. "
5.	Ischemia 01/01/2003 - "A single i.c.v. injection of neuropeptide Y 3-36 (15 microg/kg), [Leu(31),Pro(34)]-neuropeptide Y (30 microg/kg), or BIBP3226 (5, 15, or 45 microg/kg) was given at 30 min of ischemia. "

Related Drugs and Biologics

1.	Neuropeptides
2.	Neuropeptide Y
3.	BIBP 3226
4.	Peptides (Polypeptides)